These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 12751028)
1. High rate of macrolide resistance in Staphylococcus aureus strains from patients with cystic fibrosis reveals high proportions of hypermutable strains. Prunier AL; Malbruny B; Laurans M; Brouard J; Duhamel JF; Leclercq R J Infect Dis; 2003 Jun; 187(11):1709-16. PubMed ID: 12751028 [TBL] [Abstract][Full Text] [Related]
2. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004). Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477 [TBL] [Abstract][Full Text] [Related]
3. Macrolide-resistant Staphylococcus aureus colonization in cystic fibrosis patients: is there transmission to household contacts? Tramper-Stranders GA; van der Ent CK; Gerritsen SA; Fleer A; Kimpen JL; Wolfs TF J Antimicrob Chemother; 2007 Sep; 60(3):665-8. PubMed ID: 17604321 [TBL] [Abstract][Full Text] [Related]
4. Resistance to macrolides by ribosomal mutation in clinical isolates of Turicella otitidis. Boumghar-Bourtchai L; Chardon H; Malbruny B; Mezghani S; Leclercq R; Dhalluin A Int J Antimicrob Agents; 2009 Sep; 34(3):274-7. PubMed ID: 19414240 [TBL] [Abstract][Full Text] [Related]
5. Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function. Tramper-Stranders GA; Wolfs TF; Fleer A; Kimpen JL; van der Ent CK Pediatr Infect Dis J; 2007 Jan; 26(1):8-12. PubMed ID: 17195698 [TBL] [Abstract][Full Text] [Related]
6. Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis. Phaff SJ; Tiddens HA; Verbrugh HA; Ott A J Antimicrob Chemother; 2006 Apr; 57(4):741-6. PubMed ID: 16469851 [TBL] [Abstract][Full Text] [Related]
7. High prevalence in cystic fibrosis patients of multiresistant hospital-acquired methicillin-resistant Staphylococcus aureus ST228-SCCmecI capable of biofilm formation. Molina A; Del Campo R; Máiz L; Morosini MI; Lamas A; Baquero F; Cantón R J Antimicrob Chemother; 2008 Nov; 62(5):961-7. PubMed ID: 18647744 [TBL] [Abstract][Full Text] [Related]
8. Macrolide-lincosamide-resistant phenotypes and genotypes of Staphylococcus aureus isolated from bovine clinical mastitis. Wang Y; Wu CM; Lu LM; Ren GW; Cao XY; Shen JZ Vet Microbiol; 2008 Jul; 130(1-2):118-25. PubMed ID: 18272297 [TBL] [Abstract][Full Text] [Related]
9. The thymidine-dependent small-colony-variant phenotype is associated with hypermutability and antibiotic resistance in clinical Staphylococcus aureus isolates. Besier S; Zander J; Kahl BC; Kraiczy P; Brade V; Wichelhaus TA Antimicrob Agents Chemother; 2008 Jun; 52(6):2183-9. PubMed ID: 18378706 [TBL] [Abstract][Full Text] [Related]
10. Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients. Hansen CR; Pressler T; Hoiby N; Johansen HK J Cyst Fibros; 2009 Jan; 8(1):58-62. PubMed ID: 18849202 [TBL] [Abstract][Full Text] [Related]
11. Characterization of Staphylococcus aureus Strains Isolated from Czech Cystic Fibrosis Patients: High Rate of Ribosomal Mutation Conferring Resistance to MLS(B) Antibiotics as a Result of Long-Term and Low-Dose Azithromycin Treatment. Tkadlec J; Vařeková E; Pantůček R; Doškař J; Růžičková V; Botka T; Fila L; Melter O Microb Drug Resist; 2015 Aug; 21(4):416-23. PubMed ID: 25826283 [TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF). Tazumi A; Maeda Y; Goldsmith CE; Coulter WA; Mason C; Millar BC; McCalmont M; Rendall J; Elborn JS; Matsuda M; Moore JE J Antimicrob Chemother; 2009 Sep; 64(3):501-6. PubMed ID: 19584106 [TBL] [Abstract][Full Text] [Related]
13. National survey of molecular epidemiology of Staphylococcus aureus colonization in Belgian cystic fibrosis patients. Vergison A; Denis O; Deplano A; Casimir G; Claeys G; DeBaets F; DeBoeck K; Douat N; Franckx H; Gigi J; Ieven M; Knoop C; Lebeque P; Lebrun F; Malfroot A; Paucquay F; Pierard D; Van Eldere J; Struelens MJ J Antimicrob Chemother; 2007 May; 59(5):893-9. PubMed ID: 17341469 [TBL] [Abstract][Full Text] [Related]
14. Macrolide resistance genotypes and phenotypes among erythromycin-resistant clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci, Italy. Gherardi G; De Florio L; Lorino G; Fico L; Dicuonzo G FEMS Immunol Med Microbiol; 2009 Jan; 55(1):62-7. PubMed ID: 19076222 [TBL] [Abstract][Full Text] [Related]
15. Emergence of linezolid-resistant Staphylococcus aureus during treatment of pulmonary infection in a patient with cystic fibrosis. Gales AC; Sader HS; Andrade SS; Lutz L; Machado A; Barth AL Int J Antimicrob Agents; 2006 Apr; 27(4):300-2. PubMed ID: 16527459 [TBL] [Abstract][Full Text] [Related]
16. Induction of macrolide resistance in Mycoplasma gallisepticum in vitro and its resistance-related mutations within domain V of 23S rRNA. Wu CM; Wu H; Ning Y; Wang J; Du X; Shen J FEMS Microbiol Lett; 2005 Jun; 247(2):199-205. PubMed ID: 15936901 [TBL] [Abstract][Full Text] [Related]
17. Hypermutable Haemophilus influenzae with mutations in mutS are found in cystic fibrosis sputum. Watson ME; Burns JL; Smith AL Microbiology (Reading); 2004 Sep; 150(Pt 9):2947-2958. PubMed ID: 15347753 [TBL] [Abstract][Full Text] [Related]